Humoral Risk Factors Associated to Allograft Dysfunction after Lung Transplantation: The Alert of Non-HLA Auto Antibody and HLA-Donor Specific Antibody (DSA) with Non-DSA HLA Antibody

2021 ◽  
Vol 40 (4) ◽  
pp. S56-S57
Author(s):  
A. Zhang ◽  
Y. Sun ◽  
D. Thomas ◽  
J. Allen ◽  
D. Good ◽  
...  
Keyword(s):  
Risk Factors ◽  
Lung Transplantation ◽  
Specific Antibody ◽  
Factors Associated ◽  
Allograft Dysfunction ◽  
Auto Antibody ◽  
Hla Antibody

Surgical Risk Factors Associated With Lung Transplantation

2009 ◽  
Vol 41 (6) ◽  
pp. 2218-2220 ◽  
Author(s):  
M. Paradela ◽  
D. González ◽  
I. Parente ◽  
R. Fernández ◽  
M.M. De La Torre ◽  
...  
Keyword(s):  
Risk Factors ◽  
Lung Transplantation ◽  
Surgical Risk ◽  
Factors Associated

Predictive model and risk factors associated with a revised definition of early allograft dysfunction in liver transplant recipients

2017 ◽  
Vol 31 (11) ◽  
pp. e13097 ◽  
Author(s):  
Ramona Nicolau-Raducu ◽  
Ari J. Cohen ◽  
Amjad Bokhari ◽  
Humberto Bohorquez ◽  
David Bruce ◽  
...  
Keyword(s):  
Risk Factors ◽  
Liver Transplant ◽  
Predictive Model ◽  
Transplant Recipients ◽  
Factors Associated ◽  
Allograft Dysfunction ◽  
Definition Of ◽  
Liver Transplant Recipients ◽  
Early Allograft Dysfunction

Risk Factors Associated with Airway Complications after Lung Transplantation

2019 ◽  
Vol 38 (4) ◽  
pp. S224-S225
Author(s):  
A. Bery ◽  
P. Aguilar ◽  
D. Byers ◽  
D. Kreisel ◽  
H. Kulkarni ◽  
...  
Keyword(s):  
Risk Factors ◽  
Lung Transplantation ◽  
Factors Associated ◽  
Airway Complications

Fundoplication after lung transplantation in patients with systemic sclerosis–related end-stage lung disease

2021 ◽  
pp. 239719832110162
Author(s):  
Miguel M Leiva-Juárez ◽  
Andreacarola Urso ◽  
Joseph Costa ◽  
Bryan P Stanifer ◽  
Joshua R Sonett ◽  
...  
Keyword(s):  
Risk Factors ◽  
Overall Survival ◽  
Systemic Sclerosis ◽  
Lung Transplantation ◽  
Lung Transplant ◽  
Transplant Recipients ◽  
Chronic Lung Allograft Dysfunction ◽  
Allograft Dysfunction ◽  
Increased Risk ◽  
Lung Transplant Recipients

Introduction: Gastroesophageal reflux and aspiration are risk factors for chronic lung allograft dysfunction in lung transplant recipients. Patients with systemic sclerosis are at an increased risk of aspiration due to esophageal dysmotility and an ineffective lower esophageal sphincter. The aim of this study is to understand the effect of fundoplication on outcomes in systemic sclerosis recipients. Methods: Between 2001 and 2019, 168 systemic sclerosis patients were referred for lung transplantation—51 (30.3%) were listed and 36 (21.4%) were transplanted. Recipients were stratified whether they underwent a fundoplication (n = 10, 27.8%) or not (n = 26, 72.2%). Freedom from chronic lung allograft dysfunction and survival were analyzed using log-rank test. Multivariable analysis for known risk factors was performed using a Cox-proportional hazards model. Results: Median time to fundoplication after transplantation was 16.4 months (interquartile range: 9.6–25.1) and all were laparoscopic (Dor 50%, Nissen 40%, Toupet 10%). There were no differences in acute rejection ⩾ A1 (26.9% vs 30%), or primary graft dysfunction grades 2–3 at 72 h (42.3% vs 40%) between groups. Recipients with fundoplication had an increased freedom from chronic lung allograft dysfunction (p = 0.035) and overall survival (p = 0.01). Fundoplication was associated with a reduced risk of mortality adjusting for other comorbidities (hazard ratio = 0.13; 95% confidence interval = 0.02–0.65; p = 0.014). Double and single lung transplant did not have different post-transplant survival. Conclusion: Fundoplication in systemic sclerosis lung transplant recipients is associated with greater freedom from chronic lung allograft dysfunction and overall survival. Screening for reflux and aspiration followed by early fundoplication may delay graft deterioration in this population.

scholarly journals Lung Transplantation and Donor-Specific Antigens: Clinical and Serologic Factors Associated with Survival and Allograft Dysfunction

2020 ◽  
Author(s):  
D.M. Guidot ◽  
S. Ghosh ◽  
N. Madala ◽  
J. Varghese ◽  
A. Banga ◽  
...  
Keyword(s):  
Lung Transplantation ◽  
Factors Associated ◽  
Allograft Dysfunction ◽  
Specific Antigens

A Closer Look at Risk Factors Associated with Airway Complications in Lung Transplantation

2021 ◽  
Vol 40 (4) ◽  
pp. S356
Author(s):  
G. Li ◽  
B. Mankidy ◽  
Z. Liu ◽  
B. Rodrigues ◽  
H. Choi ◽  
...  
Keyword(s):  
Risk Factors ◽  
At Risk ◽  
Lung Transplantation ◽  
Factors Associated ◽  
Airway Complications

scholarly journals An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome

2014 ◽  
Vol 44 (6) ◽  
pp. 1479-1503 ◽  
Author(s):  
Keith C. Meyer ◽  
Ganesh Raghu ◽  
Geert M. Verleden ◽  
Paul A. Corris ◽  
Paul Aurora ◽  
...  
Keyword(s):  
Risk Factors ◽  
Lung Transplantation ◽  
Bronchiolitis Obliterans ◽  
Evidence Synthesis ◽  
Bronchiolitis Obliterans Syndrome ◽  
Expert Committee ◽  
European Respiratory Society ◽  
Post Transplant ◽  
Allograft Dysfunction ◽  
Definition Of

Bronchiolitis obliterans syndrome (BOS) is a major complication of lung transplantation that is associated with poor survival. The International Society for Heart and Lung Transplantation, American Thoracic Society, and European Respiratory Society convened a committee of international experts to describe and/or provide recommendations for 1) the definition of BOS, 2) the risk factors for developing BOS, 3) the diagnosis of BOS, and 4) the management and prevention of BOS.A pragmatic evidence synthesis was performed to identify all unique citations related to BOS published from 1980 through to March, 2013. The expert committee discussed the available research evidence upon which the updated definition of BOS, identified risk factors and recommendations are based. The committee followed the GRADE (Grading of Recommendation, Assessment, Development and Evaluation) approach to develop specific clinical recommendations.The term BOS should be used to describe a delayed allograft dysfunction with persistent decline in forced expiratory volume in 1 s that is not caused by other known and potentially reversible causes of post-transplant loss of lung function. The committee formulated specific recommendations about the use of systemic corticosteroids, cyclosporine, tacrolimus, azithromycin and about re-transplantation in patients with suspected and confirmed BOS.The diagnosis of BOS requires the careful exclusion of other post-transplant complications that can cause delayed lung allograft dysfunction, and several risk factors have been identified that have a significant association with the onset of BOS. Currently available therapies have not been proven to result in significant benefit in the prevention or treatment of BOS. Adequately designed and executed randomised controlled trials that properly measure and report all patient-important outcomes are needed to identify optimal therapies for established BOS and effective strategies for its prevention.

scholarly journals ACUTE KIDNEY INJURY AFTER LUNG TRANSPLANTATION: PERIOPERATIVE RISK FACTORS AND OUTCOME

2019 ◽  
Author(s):  
Enora Atchade ◽  
Samira Barour ◽  
Alexy Tran-Dinh ◽  
Sylvain Jean-Baptiste ◽  
Sébastien Tanaka ◽  
...  
Keyword(s):  
Risk Factors ◽  
Acute Kidney Injury ◽  
Multivariate Analysis ◽  
Lung Transplantation ◽  
Kidney Injury ◽  
Short Term ◽  
Factors Associated ◽  
Icu Stay ◽  
Long Term Mortality

Abstract BACKGROUND Acute kidney injury (AKI) is associated with increased short-term and long-term mortality and morbidity after lung transplantation (LT). The primary objective of this study was to analyze the perioperative factors associated with AKI according to KDIGO criteria during hospitalization in an intensive care unit (ICU) after LT. METHODS This was a single-center observational, prospective study. AKI was defined according to KDIGO criteria. Results are expressed as median, interquartile range, absolute numbers and percentages. Statistical analyses were performed using Chi-square test, Fisher’s exact test and Mann-Witney U test (p<0.05 was considered to be significant). Multivariate analysis was performed to identify independent risk factors. RESULTS Between January 2016 and April 2018, 94 patients (pts) underwent LT (70% bilateral LT). AKI occurred during ICU stay in 46 pts (49%). KDIGO 1 AKI was observed in 16 pts (17%), KDIGO 2 in 14 pts (15%), and KDIGO 3 in 16 pts (17%) including 12 pts (75%) who required renal replacement therapy (RRT). AKI occurred before the fifth day after surgery for 38 patients (82% of the AKI patients). On multivariate analysis, independent factors associated with AKI were bilateral LT and mechanical ventilation (MV) > 3 days (OR 4.26 95%CI [1.49; 13.63] p=0.010 and OR 5.56 [1.25; 11.47] p=0.018, respectively). AKI and the need for RRT were significantly associated with ICU mortality, 28-day mortality and one-year mortality. CONCLUSION AKI is common during ICU stay after LT, especially after bilateral LT and is associated with prolonged MV, and increased short-term and long-term mortality.

Sign in / Sign up

Export Citation Format

Share Document